	US 11,786,566 B2
	Bifidobacterium animalis and application of compound bacterium preparation prepared from Bifidobacterium animalis in preparing medicine for treating or preventing avian influenza virus infection
Meilin Jin, Hubei (CN); Qiang Zhang, Hubei (CN); Xiaotong Hu, Hubei (CN); Li Yang, Hubei (CN); Jin Hu, Hubei (CN); Ting Wang, Hubei (CN); Xiaomei Sun, Hubei (CN); Zhong Zou, Hubei (CN); Wenxiao Gong, Hubei (CN); and Xian Lin, Hubei (CN)
Assigned to Huazhong Agricultural University, Hubei (CN)
Filed by Huazhong Agricultural University, Hubei (CN)
Filed on Jan. 4, 2021, as Appl. No. 17/141,104.
Claims priority of application No. 202010031196.6 (CN), filed on Jan. 13, 2020.
Prior Publication US 2021/0213075 A1, Jul. 15, 2021
Int. Cl. A61K 35/745 (2015.01); A61P 31/16 (2006.01)

CPC A61K 35/745 (2013.01) [A61P 31/16 (2018.01)]

4 Claims

1. A method for treating avian influenza virus H7N9 infection, comprising

preparing a composition comprising Bifidobacterium animalis ATCC Accession No. 25527, wherein an effective bacterial concentration of the composition is equal to or greater than 1×10⁹CFU/ml, and

administering the composition to a subject in need of treatment for avian influenza virus H7N9 infection, and

regulating cytokine-related immune response and inhibiting proliferation of avian influenza virus H7N9 in the subject.